Abnormalities in mineral and bone metabolism occur early in the course of renal failure and uremic bone disease is a major contributing factor to the morbidity of patients with end-stage renal failure. In addition, new therapeutic approaches have generated new outlooks, problems and controversies. This article reviews our current accepted knowledge, the present numerous controversies, unresolved questions, new issues and new horizons.
|Number of pages||16|
|Journal||Mineral and Electrolyte Metabolism|
|State||Published - 1991|
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism